期刊文献+

尿NGAL在2型糖尿病肾病肾小管间质损伤评价中的价值 被引量:6

Value of urinary neutrophil gelatinase-associated lipocalin in evaluation of renal tubulointerstitial injury of type 2 diabetic nephropathy
原文传递
导出
摘要 目的探讨尿中性粒细胞明胶酶相关载脂蛋白(NGAL)对评价2型糖尿病肾病(DN)患者肾小管间质损伤的价值。方法研究对象为2012年1月至2015年12月第三军医大学大坪医院2型糖尿病患者167例(2型糖尿病组);将2型糖尿病组再分为正常白蛋白尿组(n=56)、微量白蛋白尿组(n=58)、大量白蛋白尿组(n=53),其中51例患者进行了肾活检。50例非糖尿病患者作为正常对照组。采用酶联免疫吸附测定方法检测尿液中NGAL水平,分光光度法测定尿N-乙酰-β-D-葡萄糖苷酶(NAG)。分析尿NGAL水平与肾功能相关指标[尿NAG、尿白蛋白/肌酐比值(ACR)、e GFR]及肾组织损伤病理评分之间的相关性,以及NGAL对DN肾小管间质损伤严重程度的评价效能,采用SPSS软件进行统计学分析,相关性分析采用Pearson或Spearman方法。结果糖尿病患者尿NGAL水平较非糖尿病正常对照组明显增加;尿NGAL水平与尿NAG、ACR呈正相关(r=0.528,0.578,P<0.001),与e GFR呈负相关(r=-0.637,P<0.001);尿NGAL水平与DN肾小管萎缩与间质纤维化(IFTA)的严重程度呈显著正相关(r=0.652,P<0.001);尿NGAL曲线下面积最大(AUC=0.868),特异度94.7%,敏感度71.9%。结论尿NGAL是评价DN肾小管间质损伤理想的生物标志物之一。 Objective To investigate the value of urinary neutrophil gelatinase-associated lipocalin (NGAL)in evaluation of renal tubulointerstitial injury of type 2 diabetic nephropathy (DN).Methods 167 patients with type 2 diabetes and 50 patients without diabetes were recruited in this study from the Department of Nephrology of Daping Hospital from January of 2012 to December of 2015.The diabetic patients were categorized into normoalbuminuria group (n =56),microalbuminuria group (n =58),and macroalbuminuria group (n=53),among whom 51 patients received renal biopsies.Urinary NGAL levels were measured by ELISA,and urinary NAG levels were measured by the spectrophotometric method. Analysis was made for correlation of urinary NGAL with renal function parameters, and with renal histopathological sores.The value of urinary NGAL in evaluation of renal tubulointerstitial injury of DN was also analyzed.Results Urinary NGAL levels were elevated in diabetic patients compared with the non-diabetes control.Urinary NGAL levels were positively associated with both urinary NAG (r=0.528,P〈0.001)and ACR (r =0.578,P〈0.001),and negatively associated with eGFR (r =-0.637,P〈0.001).Urinary NGAL levels were significantly correlated with scores of renal tubular atrophy and interstitial fibrosis (r=0.652,P〈0.001 )in DN.Urinary NGAL had the largest area under the curve (AUC=0.868),with a specificity of 94.7% and a sensitivity of 71.9%.Conclusion Urinary NGAL could serve as one of the most ideal biomarkers for evaluating the tubulointerstitial injury in DN.
出处 《中华肾病研究电子杂志》 2016年第4期163-167,共5页 Chinese Journal of Kidney Disease Investigation(Electronic Edition)
基金 国家自然科学基金面上项目(81470962) 国家十二五科技支撑计划项目子课题(2011BAI10B08)
关键词 中性粒细胞明胶酶相关载脂蛋白 糖尿病肾病 肾小管间质损伤 生物标志物 Neutrophil gelatinase-associated lipocalin Diabetic nephropathy Renal tubulointerstitial injury Biomarker
  • 相关文献

参考文献17

  • 1KDOQI. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease [ J]. Am J Kidney Dis, 2007, 49(2 Suppl 2) : S12-S154.
  • 2Tang SC, Lai KN. The pathogenic role of the renal proximal tubular cell in diabetic nephropathy [ J]. Nephrol Dial Transplant, 2012, 27 (8) : 3049-3056.
  • 3Okada T, Nagao T, Matsumoto H, et al. Histological predictors for renal prognosis in diabetic nephropathy in diabetes mellitus type 2 patients with overt proteinttria [J]. Nephrology, 2012, 17(1): 68-75.
  • 4Nauta FL, Boertien WE, Bakker SJ, et al. Glomerular and tubular damage markers are elevated in patients with diabetes [ J]. Diabetes Care, 2011, 34(4): 975-981.
  • 5Waanders F, Naris G, van Goor H, et al. Urinary tubular biomarkers of kidney damage: potential value in clinical practice [J]. Am J Kidney Dis, 2010, 55(5): 813-816.
  • 6Roblesosorio ML, Sabath E. Tubular dysfunction and albuminuric renal disease in subjects with type 2 diabetes mellitus [ J]. Rev Invest Clin, 2014, 66(3) ; 234-239.
  • 7Macisaac RJ, Ekinci EI, Jerums G. Markers of and risk factors for the development and progression of diabetic kidney disease [ J]. Am J Kidney Dis, 2014, 63(2 Suppl 2) : 39-62.
  • 8Hojs R, Ekart R, Bevc S, et al. Biomarkers of renal disease and progression in patients with diabetes [J]. J Clin Med, 2015, 4(5) : 1010-1024.
  • 9National Kidney Foundation. KDOQI clinical practice guideline for diabetes and CKD: 2012 update [J]. Am J Kidney Dis, 2012, 60 (5) : 850-886.
  • 10Boliguano D, Donato V, Coppolino G, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage [J]. Am J Kidney Dis, 2008, 52(3) : 595-605.

同被引文献69

引证文献6

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部